Status | Study |
Recruiting |
Study Name: Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients Condition: Tubular Breast Cancer Mucinous Breast Cancer Date: 2014-07-14 Interventions: Drug: Paclitaxel Other Name: T |
Completed |
Study Name: Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer Condition: Tubular Breast Cancer Mucinous Breast Cancer Date: 2014-07-14 Interventions: Drug: Paclitaxel Other Name: T |
Recruiting |
Study Name: Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT) Condition: Invasive Ductal Breast Cancer Carcinoma Breast Stage I Date: 2013-09-25 Interventions: Radiation: Intraoperative Electron Radiotherapy Intraoperative Electron Radiotherapy (IOERT) is delivere |
Recruiting |
Study Name: Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer Condition: Carcinoma, Ductal, Breast Date: 2013-05-14 Interventions: Procedure: Biopsy before and after three weeks of study treatment |
Recruiting |
Study Name: BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer Condition: Estrogen Receptor-positive Breast Cancer HER2-negative Breast Cancer Date: 2013-02-11 Interventions: Drug: PI3K inhibitor BYL719 Gi |
Terminated |
Study Name: Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Condition: Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II Date: 2013-02-06 Interventions: Dietary Supplement: Vitamin D Subjects will be assigned to a dosage level between 600IU daily and 10,000 |
Completed |
Study Name: Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer Condition: Female Breast Neoplasms Carcinoma, Ductal, Breast Date: 2011-12-15 Interventions: Procedure: axillary dissection Conservative breast surgery with or without axillary dissection |
Completed |
Study Name: Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ Condition: Breast Cancer Date: 2010-05-26 Interventions: Genetic: RNA analysis Genetic: gene expres |
Completed |
Study Name: 4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ Condition: Ductal Breast Carcinoma in Situ Estrogen Receptor-positive Brea Date: 2009-08-04 Interventions: Drug: oral placebo Oral placeb |
Recruiting |
Study Name: Contrast-Enhanced MRI in Women With Ductal Breast Carcinoma in Situ and in Healthy Volunteers Condition: Breast Cancer Date: 2008-12-05 Interventions: Procedure: contrast-enhanced magnetic resonance imaging |